Details for 2019215699
Up to date per 03.04.2026
Actions
Details for 2019215699
Deleted
European Patent
27.05.2020 A
24.08.2022 B1
28.04.2011
SE
1150371
15.09.2011
US
201161535126 P
A61K 38/05 20060101AFI20210901BHEP
Owner
Oncopeptides Innovation ABLuntmakargatan 46111 37 StockholmSE
Representative
Representative
Weiser Voith Gugler Patentanwälte PartnerschaftKopfgasse 71130 WienAT
Inventor
SPIRA, JackNäsbyvägen 38 135 53 TyresöSE
LEHMANN, FredrikKanalvägen 61 191 34 SollentunaSE